Work

P06 Competing CNS or Systemic Progression Analysis for EGFR Mutation-Positive NSCLC Patients on Afatinib in LUX-Lung 3, 6, and 7

Year: 2018

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2018.07.045

Authors: J.C.-. Yang, Y. Wu, V. Hirsh, K. O’Byrne, N. Yamamoto, S. Popat, A. Tamiya, D. Kaen, A. Märten, M. Schuler

Institutions: National Taiwan University Hospital, Guangdong General Hospital, Guangdong Academy of Medical Sciences, McGill University, Princess Alexandra Hospital, Wakayama Medical University, Royal Marsden Hospital, NHO Kinki Chuo Chest Medical Center, Boehringer Ingelheim (Germany), Essen University Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2891818905

Cites:

Cited by:

Related to: 10